tiprankstipranks
Trending News
More News >
Shanrong Biotechnology Corp (SRBT)
OTHER OTC:SRBT
US Market

Shanrong Biotechnology (SRBT) Financial Statements

Compare
5 Followers

Shanrong Biotechnology Financial Overview

Shanrong Biotechnology's market cap is currently $205.10K. The company's EPS TTM is $-0.034; its P/E ratio is -1.29; Shanrong Biotechnology is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 17
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00
Operating Income$ -78.99K$ -31.75K
EBITDA$ -78.99K$ -31.75K
Net Income$ -78.98K$ -31.75K
Balance Sheet
Cash & Short-Term Investments$ 18.30K$ 24.78K
Total Assets$ 18.30K$ 24.78K
Total Debt$ 0.00$ 0.00
Net Debt$ -18.30K$ -24.78K
Total Liabilities$ 97.28K$ 63.99K
Stockholders' Equity$ -76.98K$ -39.21K
Cash Flow
Free Cash Flow$ -77.17K$ -31.75K
Operating Cash Flow$ -77.17K$ -31.75K
Investing Cash Flow$ 0.00$ 0.00
Financing Cash Flow$ 95.47K$ 56.53K
Currency in USD

Shanrong Biotechnology Earnings and Revenue History

Shanrong Biotechnology Debt to Assets

Shanrong Biotechnology Cash Flow

Shanrong Biotechnology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.